DZ1988A1 - Thérapie de combinaison pour le traitement de l'hiv. - Google Patents

Thérapie de combinaison pour le traitement de l'hiv.

Info

Publication number
DZ1988A1
DZ1988A1 DZ960029A DZ960029A DZ1988A1 DZ 1988 A1 DZ1988 A1 DZ 1988A1 DZ 960029 A DZ960029 A DZ 960029A DZ 960029 A DZ960029 A DZ 960029A DZ 1988 A1 DZ1988 A1 DZ 1988A1
Authority
DZ
Algeria
Prior art keywords
winter
treatment
combination therapy
therapy
combination
Prior art date
Application number
DZ960029A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DZ1988A1 publication Critical patent/DZ1988A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DZ960029A 1995-02-01 1996-01-31 Thérapie de combinaison pour le traitement de l'hiv. DZ1988A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/382,113 US6689761B1 (en) 1995-02-01 1995-02-01 Combination therapy for HIV infection

Publications (1)

Publication Number Publication Date
DZ1988A1 true DZ1988A1 (fr) 2002-07-20

Family

ID=23507574

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ960029A DZ1988A1 (fr) 1995-02-01 1996-01-31 Thérapie de combinaison pour le traitement de l'hiv.

Country Status (37)

Country Link
US (1) US6689761B1 (fr)
EP (1) EP0806957B1 (fr)
JP (1) JPH10513186A (fr)
KR (1) KR19980701856A (fr)
CN (1) CN1160081C (fr)
AR (1) AR002957A1 (fr)
AT (1) ATE243519T1 (fr)
AU (1) AU711176B2 (fr)
BR (1) BR9607714A (fr)
CA (1) CA2211973A1 (fr)
CO (1) CO4700430A1 (fr)
CZ (1) CZ244497A3 (fr)
DE (1) DE69628819T2 (fr)
DK (1) DK0806957T3 (fr)
DZ (1) DZ1988A1 (fr)
EA (1) EA000437B1 (fr)
EE (1) EE03514B1 (fr)
ES (1) ES2200052T3 (fr)
FI (1) FI973184L (fr)
HR (1) HRP960045B1 (fr)
HU (1) HUP9800810A3 (fr)
IL (1) IL116925A (fr)
IS (1) IS1970B (fr)
MX (1) MX9705916A (fr)
MY (1) MY121604A (fr)
NO (1) NO314568B1 (fr)
NZ (1) NZ302153A (fr)
PE (1) PE38397A1 (fr)
PL (1) PL182742B1 (fr)
PT (1) PT806957E (fr)
SA (1) SA96160669B1 (fr)
SK (1) SK103797A3 (fr)
TR (1) TR199700735T1 (fr)
TW (1) TW442291B (fr)
WO (1) WO1996023509A1 (fr)
YU (1) YU49417B (fr)
ZA (1) ZA96722B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0942747A1 (fr) * 1996-08-26 1999-09-22 Chiron Corporation Therapie de vaccination apres l'infection par le virus de l'immunodeficience humaine (vih)
AU6761198A (en) * 1998-03-17 1999-10-11 Julianna Lisziwiewicz Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
CA2374198A1 (fr) * 1998-05-29 1999-12-02 Maki Arai Therapie combinee pour le traitement des infections dues au vif
EP1980617A1 (fr) 1998-12-31 2008-10-15 Novartis Vaccines and Diagnostics, Inc. Expression améliorée de polypeptides HIV et production de particules de type virus
WO2000039304A2 (fr) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides codant pour des polypeptides antigeniques du type c du vih; polypeptides et leurs utilisations
CA2452015C (fr) 2001-07-05 2012-07-03 Chiron Corporation Polynucleotides codant des polypeptides de type c du vih antigeniques, polypeptides et leurs utilisations
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CA2583195A1 (fr) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Procede visant a traiter l'infection a vih par l'administration combinee du tipranavir et du reverset
WO2007012177A1 (fr) * 2005-07-27 2007-02-01 Emil Toma Compositions de lamivudine (3tc) potentialisées par la zalcitabine (ddc) pour traitement antirétroviral
WO2018128993A1 (fr) * 2017-01-04 2018-07-12 Oyagen, Inc. Composés, compositions et méthodes pour le traitement du virus de l'immunodéficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
RU2139052C1 (ru) 1993-03-31 1999-10-10 Мерк Энд Ко., Инк. Комбинация ингибитора вич-протеазы с другими антивирусными соединениями, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
IL114208A0 (en) 1994-06-27 1995-10-31 Merck & Co Inc Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors

Also Published As

Publication number Publication date
CZ244497A3 (cs) 1998-01-14
PT806957E (pt) 2003-10-31
CN1160081C (zh) 2004-08-04
CA2211973A1 (fr) 1996-08-08
CO4700430A1 (es) 1998-12-29
TR199700735T1 (xx) 1998-02-21
IL116925A0 (en) 1996-05-14
HUP9800810A3 (en) 2001-05-28
TW442291B (en) 2001-06-23
YU49417B (sh) 2006-01-16
EA199700150A1 (ru) 1997-12-30
MY121604A (en) 2006-02-28
IS4533A (is) 1997-07-29
PL321660A1 (en) 1997-12-22
AU711176B2 (en) 1999-10-07
IS1970B (is) 2004-12-15
KR19980701856A (ko) 1998-06-25
ZA96722B (en) 1996-08-26
PE38397A1 (es) 1997-10-09
EE03514B1 (et) 2001-10-15
FI973184A7 (fi) 1997-09-30
FI973184A0 (fi) 1997-07-31
BR9607714A (pt) 1998-01-13
NO973533D0 (no) 1997-07-31
PL182742B1 (pl) 2002-02-28
DK0806957T3 (da) 2003-09-29
NZ302153A (en) 1998-12-23
CN1179722A (zh) 1998-04-22
DE69628819T2 (de) 2004-05-13
AU4774896A (en) 1996-08-21
ES2200052T3 (es) 2004-03-01
HK1004659A1 (en) 1998-12-04
EP0806957A1 (fr) 1997-11-19
EP0806957B1 (fr) 2003-06-25
EE9700165A (et) 1998-02-16
HRP960045A2 (en) 1997-10-31
US6689761B1 (en) 2004-02-10
WO1996023509A1 (fr) 1996-08-08
MX9705916A (es) 1997-10-31
SA96160669B1 (ar) 2006-07-30
ATE243519T1 (de) 2003-07-15
EA000437B1 (ru) 1999-08-26
HUP9800810A2 (hu) 1998-07-28
FI973184L (fi) 1997-09-30
IL116925A (en) 2000-07-26
NO314568B1 (no) 2003-04-14
JPH10513186A (ja) 1998-12-15
HRP960045B1 (en) 2004-06-30
NO973533L (no) 1997-10-01
SK103797A3 (en) 1998-02-04
YU6396A (sh) 1999-06-15
DE69628819D1 (de) 2003-07-31
AR002957A1 (es) 1998-05-27

Similar Documents

Publication Publication Date Title
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
FR2685206B1 (fr) Dispositif de drainage implantable pour le traitement de l'hydrocephalie.
DZ2396A1 (fr) Traitement de l'eau
FR2698780B1 (fr) Catheter pour le traitement d'un tissu pathologique.
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
FR2675597B1 (fr) Unite de traitement d'electrophotographie.
EP0601058A4 (fr) Formulations transdermiques pour l'administration de prazosine.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
EP0959879A4 (fr) Therapie photodynamique pour le traitement de l'arthrose
EP0689455A4 (fr) Strategies therapeutiques pour le traitement d'infections virales groupees immuno-infectieuses
FR2746658B1 (fr) Valve de drainage implantable pour le traitement de l'hydrocephalie
EP0761604A3 (fr) Agent pour le traitement des eaux
FR2710267B3 (fr) Composition pour le traitement de l'impuissance masculine.
FR2758465B1 (fr) Composition pour le traitement de l'amiante
ITMI931181A1 (it) Procedimento per l'ulteriore trattamento di salcicce
FR2693129B1 (fr) Outillage pour le traitement électrochimique de la surface interne d'un tube.
DZ2012A1 (fr) Benzamides pour le traitement de dégénérescences neurologiques.
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
EP0859761A4 (fr) 4-azasteroides utilises pour le traitement d'etats hyperandrogeniques
EP0671500A3 (fr) Compositions pour le traitement de textiles.
NO982562D0 (no) Sammensetning for behandling av smerte
FR2751637B1 (fr) Cellule d'electrocoagulation pour le traitement d'effluents
EP0667157A4 (fr) Traitement symptomatique des troubles circulatoires.